Literature DB >> 25253393

Role of the non-enzymatic metabolite of eicosapentaenoic acid, 5-epi-5-F3t-isoprostane in the regulation of [ (3)H]D-aspartate release in isolated bovine retina.

Jamal Jamil1, Pratik Bankhele, Ankita Salvi, Jaimee E Mannix, Camille Oger, Alexandre Guy, Jean-Marie Galano, Thierry Durand, Ya Fatou Njie-Mbye, Sunny E Ohia, Catherine A Opere.   

Abstract

We have evidence that F2-isoprostanes (F2-IsoPs) regulate the release of excitatory neurotransmitters in isolated bovine retina. Although 5-F3-IsoPs are generated in mammals, in vivo, their pharmacological actions on neurotransmitter release remain unknown. In this study, we investigated the effect of 5-epi-5-F3t-IsoP on K(+)-evoked [(3)H]D-aspartate release in isolated bovine retina using the superfusion method. Furthermore, we examined the role of arachidonic acid metabolites in the regulation of the neurotransmitter release by this novel IsoP. In the concentration range, 0.01 nM-0.1 µM, 5-epi-5-F3t-IsoP inhibited K(+)-evoked [(3)H]D-aspartate release in a concentration-dependent manner, achieving a maximum inhibition of 46.9 % at 0.1 µM (IC30 = 1 nM). The prostanoid receptor antagonists, AH 6809 (EP1-3/DP; 10 µM), SC 51322 (EP1; 10 µM) and SC 19220 (EP1; 1 µM) partially reversed 5-epi-5-F3t-IsoP-mediated inhibition of K(+)-induced [(3)H]D-aspartate release. Pretreatment of retinal tissues with the cyclooxygenase (COX) inhibitor, flurbiprofen (3 μM) unmasked a biphasic action of 5-epi-5-F3t-IsoP that was inhibitory at lower (0.1-10 pM) and stimulatory at higher concentrations (≥0.1 nM). The prostanoid pathway antagonists, BAY-u3405 (10 μM; TP/DP-receptors), SQ 29548 (10 μM; TP-receptor) and ozagrel (10 μM; Tx-synthase inhibitor) abolished the stimulatory action of the 5-epi-5-F3t-IsoP (0.1 μM) on neurotransmitter release. In conclusion, 5-epi-5-F3t-IsoP attenuates K(+)-induced [(3)H]D-aspartate release in a concentration-dependent manner by mechanisms that are partially dependent on activation of pre-junctional prostanoid EP1-receptors. Moreover, blockade of the COX-pathway unmasks a biphasic action for 5-epi-5-F3t-IsoP that is inhibitory at low concentrations and stimulatory at higher concentrations. Products of the thromboxane synthase pathway may partially account for the stimulatory action of this F3-IsoP on isolated bovine retina.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25253393     DOI: 10.1007/s11064-014-1436-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  44 in total

1.  Quantification of in vivo oxidative damage in Caenorhabditis elegans during aging by endogenous F3-isoprostane measurement.

Authors:  Christiaan F Labuschagne; Edwin C A Stigter; Margriet M W B Hendriks; Ruud Berger; Joshua Rokach; Hendrik C Korswagen; Arjan B Brenkman
Journal:  Aging Cell       Date:  2013-01-30       Impact factor: 9.304

2.  Regulation of [³H]d-aspartate release by the 5-F(2t)-isoprostane and its 5-epimer in isolated bovine retina.

Authors:  Jamal Jamil; Ashley Wright; Na'cara Harrison; Edem Kegey; Arnecia Faye Flowers; Namonique Jarell Flyod; Casey Kotera; Alexandre Guy; Jean-Marie Galano; Thierry Durand; Ya Fatou Njie-Mbye; Sunny E Ohia; Catherine A Opere
Journal:  Neurochem Res       Date:  2011-11-13       Impact factor: 3.996

3.  In vivo effect of 8-epi-PGF2alpha on retinal circulation in diabetic and non-diabetic rats.

Authors:  E Michoud; M Lecomte; M Lagarde; N Wiernsperger
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1998-12       Impact factor: 4.006

4.  Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors.

Authors:  K Takahashi; T M Nammour; M Fukunaga; J Ebert; J D Morrow; L J Roberts; R L Hoover; K F Badr
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

Review 5.  Regulation of neurotransmitter release from ocular tissues by isoprostanes.

Authors:  Catherine A Opere; Kim Ford; Min Zhao; Sunny E Ohia
Journal:  Methods Find Exp Clin Pharmacol       Date:  2008-11

6.  Effect of 8-iso prostaglandin E2 on aqueous humor dynamics in monkeys.

Authors:  R F Wang; P Y Lee; T W Mittag; S M Podos; J B Serle; B Becker
Journal:  Arch Ophthalmol       Date:  1998-09

Review 7.  Beyond prostaglandins--chemistry and biology of cyclic oxygenated metabolites formed by free-radical pathways from polyunsaturated fatty acids.

Authors:  Ullrich Jahn; Jean-Marie Galano; Thierry Durand
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

8.  Novel eicosapentaenoic acid-derived F3-isoprostanes as biomarkers of lipid peroxidation.

Authors:  Wen-Liang Song; Georgios Paschos; Susanne Fries; Muredach P Reilly; Ying Yu; Joshua Rokach; Chih-Tsung Chang; Pranav Patel; John A Lawson; Garret A Fitzgerald
Journal:  J Biol Chem       Date:  2009-06-11       Impact factor: 5.157

9.  The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase.

Authors:  A Voss; M Reinhart; S Sankarappa; H Sprecher
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

10.  Survey of n-3 and n-6 polyunsaturated fatty acids in fish and fish products.

Authors:  Claudia Strobel; Gerhard Jahreis; Katrin Kuhnt
Journal:  Lipids Health Dis       Date:  2012-10-30       Impact factor: 3.876

View more
  3 in total

1.  Comparative Effects of Hydrogen Sulfide-Releasing Compounds on [3H]D-Aspartate Release from Bovine Isolated Retinae.

Authors:  Pratik Bankhele; Ankita Salvi; Jamal Jamil; Fatou Njie-Mbye; Sunny Ohia; Catherine A Opere
Journal:  Neurochem Res       Date:  2018-01-20       Impact factor: 3.996

Review 2.  Assessment of Isoprostanes in Human Plasma: Technical Considerations and the Use of Mass Spectrometry.

Authors:  Yiu Yiu Lee; Jean-Marie Galano; Camille Oger; Claire Vigor; Reversat Guillaume; Jérôme Roy; Jean-Yves Le Guennec; Thierry Durand; Jetty Chung-Yung Lee
Journal:  Lipids       Date:  2016-09-26       Impact factor: 1.880

Review 3.  Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions.

Authors:  Simon C Dyall; Laurence Balas; Nicolas G Bazan; J Thomas Brenna; Nan Chiang; Felipe da Costa Souza; Jesmond Dalli; Thierry Durand; Jean-Marie Galano; Pamela J Lein; Charles N Serhan; Ameer Y Taha
Journal:  Prog Lipid Res       Date:  2022-05-01       Impact factor: 14.673

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.